跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,860 条关于
“SDH-deficient GIST”
全部
8,860
临床试验
7,604
药物
552
机构
47
资讯
657
3个月前
Rogaratinib Achieves 41.7% Response Rate in SDH-Deficient GIST, Demonstrating Breakthrough Efficacy for Previously Untreatable Tumor Subtype
9个月前
Ascentage Pharma's Olverembatinib Shows 23.1% Response Rate in Rare GIST Subtype with Novel Lipid Metabolism Mechanism
去年
Olverembatinib's New Indication for CML-CP Included in China's NRDL
去年
Uninterrupted Imatinib Use Improves Outcomes in Advanced GIST
3个月前
GSK Accelerates Velzatinib Phase III Trial Following Promising First-Line GIST Results
去年
Molecular Testing and Circulating Tumor DNA Advances Set to Transform GIST Management
8个月前
DCC-3009 Phase 1/2 Trial Targets Resistance Mutations in Advanced GIST Patients
去年
Onco360 Partners with Deciphera to Distribute QINLOCK for Advanced GIST Patients
去年
Ripretinib Demonstrates Efficacy as Neoadjuvant Therapy for GIST in First Case Report
去年
Deciphera's Qinlock Fails Phase 3 Trial in Second-Line GIST, Shares Plummet 75%
第 1 页,共 66 页
上一页
下一页